By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Cannabis NewsCannabis News
  • Cannabis
  • CBD
  • Science
  • Culture & Arts
  • Cannabis Press Releases
  • More
    • About Maryjanes Post
    • Cannabis Advertising
    • Cannabis Partnerships
Reading: Global Cannabis Testing Market Insights and Projections, 2022-2027 – Agilent Technologies, Shimadzu Scientific Instruments, Merck (Sigma Aldrich), Restek, and PerkinElmer are Dominating the Industry – ResearchAndMarkets.com
Share
Aa
Aa
Cannabis NewsCannabis News
Search
  • Topics
    • Business
    • Cannabis
    • Cannabis Tech
    • Culture & Arts
    • Industry Leaders
    • Cannabis Press Releases
  • Topics
    • Business
    • Cannabis
    • Cannabis Tech
    • Culture & Arts
    • Industry Leaders
    • Cannabis Press Releases
  • About Maryjanes Post
    • Ambassador
    • Cannabis Partnerships
Follow US
  • Ad Choices
  • RSS Terms of Service
© 2018 - 2022 MaryJanes Post Media. All Rights Reserved.
Cannabis News > Cannabis Press Releases > Global Cannabis Testing Market Insights and Projections, 2022-2027 – Agilent Technologies, Shimadzu Scientific Instruments, Merck (Sigma Aldrich), Restek, and PerkinElmer are Dominating the Industry – ResearchAndMarkets.com
Cannabis Press Releases

Global Cannabis Testing Market Insights and Projections, 2022-2027 – Agilent Technologies, Shimadzu Scientific Instruments, Merck (Sigma Aldrich), Restek, and PerkinElmer are Dominating the Industry – ResearchAndMarkets.com

Business Wire
Last updated: 2022/06/03 at 12:09 PM
Business Wire Published June 3, 2022
Share
SHARE

DUBLIN–(BUSINESS WIRE)–The “Cannabis Testing Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022-2027)” report has been added to ResearchAndMarkets.com’s offering.

logo Cannabis Media & PR

The global cannabis testing market was valued at USD 950.9 million in 2020, and it is expected to reach USD 1,801.51 million by 2026, registering a CAGR of 11.29% during the forecast period, 2021-2026.

The impact of COVID-19 on this industry is still being studied. On one hand, due to the shutdown of non-essential labs and testing facilities across the world in response to COVID-19 induced lockdowns, sales of cannabis testing equipment and services were a bit low.

However, there has been positive news too. In April 2020, two Israel-based companies, Eybna and CannaSoul, collaborated to work on a patented cannabis terpene formulation for treating COVID-19. The companies are examining the efficacy of the cannabis terpene formulation NT-VRL, which is being used to treat a diverse range of inflammatory conditions, including the cytokine storm syndrome caused by COVID-19. Collaborations and increased research in this segment are likely to create demand for cannabis testing services to isolate novel compounds.

The major factor attributing to the growth of the market is the increasing approval for the use of medical cannabis. The legal usage of cannabis for medical purposes is steadily growing but varies across countries based on the possession, distribution, cultivation, and medical indications for its consumption. In addition, there is an increasing volume of research supporting the use of marijuana for medical purposes, while some studies demonstrated it to be a potential means of fighting the opioid epidemic. Government bodies of several countries across North America, Europe, and South America have legalized the use of medicinal marijuana completely or for limited usage in certain forms on a strict basis.

Globally, there are about 40 countries that allow the legal use of marijuana that is distributed through prescription or limited use in ayurvedic medicines. The use of hemp-based products has seen favorable legislation since the passage of the United States Farm Bill in 2018. The bill allowed the broad-based cultivation of hemp while restricting it to pilot programs for studying market interest in hemp-derived products. The bill explicitly allowed the transfer of hemp-derived products across state lines for commercial or other purposes. Additionally, it puts no restrictions on the sale, transport, or possession of hemp-derived products, so long as those items are produced in a manner consistent with the law.

In February 2021, lawmakers in the United States stated that they were planning new legislation that would end the federal prohibition on marijuana, which has been legalized to some degree by many states. These initiatives are likely to impact the demand for cannabis testing equipment in a positive manner. As cannabis-based products find increased legislation and come under the ambit of law, the demand for testing equipment is expected to increase during the study period.

Cannabis extracts are also used to treat many neurological and mental disorders. As the incidence of these disorders increases, along with the increase in use and production of cannabis, the cannabis testing market is also expected to grow during the forecast period. According to the World Health Organization, as of 2019, approximately 450 million people suffer from such conditions, placing mental disorders among the leading causes of ill-health and disability globally.

Depression is the most common mental disorder. Globally, more than 264 million people of all ages suffer from depression. More women are affected by depression than men. Furthermore, growing awareness and adoption of software services in labs testing cannabis are other factors boosting the market. However, the high cost involved in cannabis testing instruments is a major drawback of the market growth.

Key Market Trends

  • The Analytical Instruments Segment is Dominating the Market
  • North America Dominates the Market and is Expected to do the Same During the Forecast Period

Competitive Landscape

The cannabis testing market is moderately consolidated and consists of some major players. Some of the companies currently dominating the market are Agilent Technologies, Shimadzu Scientific Instruments, Merck, Restek Corporation, PerkinElmer, Danaher Corporation, Accelerated Technology Laboratories, Steep Hill Halent Laboratories, Digipath, and Pharmlabs.

Key Topics Covered

1 INTRODUCTION

1.1 Study Assumptions and Market Definition

1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Legalization of Cannabis for Various Medical Purposes

4.2.2 Increasing Awareness regarding Cannabis for Treating Neurological Diseases

4.3 Market Restraints

4.3.1 High Cost of Analytical Instruments

4.4 Porter’s Five Forces Analysis

5 MARKET SEGMENTATION

5.1 By Product and Software/Service

5.1.1 Analytical Instruments

5.1.2 Spectroscopy Instruments

5.1.3 Consumables

5.1.4 Cannabis Testing Software and Services

5.2 By Type

5.2.1 Potency Testing

5.2.2 Terpene Profiling

5.2.3 Residual Solvent Screening

5.2.4 Heavy Metal Testing

5.2.5 Mycotoxin Testing

5.2.6 Other Types

5.3 By End-user

5.3.1 Laboratories

5.3.2 Cannabis Drug Manufacturers and Dispensaries

5.3.3 Other End-users

5.4 Geography

5.4.1 North America

5.4.2 Europe

5.4.3 Asia-Pacific

5.4.4 Middle-East and Africa

5.4.5 South America

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

6.1.1 Agilent Technologies Inc.

6.1.2 Shimadzu Scientific Instruments

6.1.3 Merck KGaA (Sigma Aldrich)

6.1.4 Restek Corporation

6.1.5 PerkinElmer Inc.

6.1.6 Danaher Corporation

6.1.7 Accelerated Technology Laboratories Inc.

6.1.8 Steep Hill Halent Laboratories Inc.

6.1.9 Digipath Inc.

6.1.10 Pharmlabs LLC

6.1.11 Sartorius AG

6.1.12 AB Sciex Pte. Ltd.

6.1.13 ENCORE Labs

6.1.14 Aurum Labs

6.1.15 WATERS

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit https://www.researchandmarkets.com/r/wt760c

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

You Might Also Like

 Flower One Obtains Meeting Order Under the Companies’ Creditors Arrangement Act (Canada)

United States Alternative Adult Beverages Market Report 2022: The Burgeoning Adult Beverage Segment Expanding the Adult Beverage Horizon – ResearchAndMarkets.com

Global Cannabidiol Market Report 2022: Growing Acceptance and Use of Products Due to Government Approvals Drives Sector – ResearchAndMarkets.com

Organigram Launches HOLY MOUNTAIN to Further Support Its Strong Position in the Dried Flower and Hash Categories

Leafly to Participate at Upcoming Investor Conferences

TAGGED: Business Wire
Business Wire June 3, 2022
Share this Article
Twitter Reddit Email Copy Link
Previous Article Fluence and JEM Farms Collaboration Shows Increased Yields, Lower Energy Consumption Under 100% LED Lighting Strategy
Next Article Columbia Care to Present at Cannabis Conference on June 7, 2022

Cannabis News and More

Work with an experienced cannabis media firm to provide your brand with the exposure it needs.

Cannabis Topics

  • Cannabis
  • Business
  • CBD
  • Cannabis Science
  • Culture & Arts

Company

  • About Maryjanes Post
  • Contact Cannabis Media
  • Contributor Guidelines

Terms of Use

  • TERMS
  • PRIVACY
  • CONTRIBUTOR AGREEMENT
  • DMCA

Resources

  • Write For UsNew
  • Media KitNew
  • Cannabis Advertising
  • Cannabis Partnerships
  • Cannabis Press ReleaseNew
Cannabis NewsCannabis News
Follow US

© 2018 - 2022 MaryJanes Post Media. All Rights Reserved.

  • Ad Choices
  • RSS Terms of Service
Go to mobile version
Welcome Back!

Sign in to your account

Lost your password?